The Genomic Landscape of Oceania

Consuelo D. Quinto-Cortés, Carmina Barberena Jonas, Sofía Vieyra-Sánchez, Stephen Oppenheimer, Ram González-Buenfil, Kathryn Auckland, Kathryn Robson, Tom Parks, J. Víctor Moreno-Mayar, Javier Blanco-Portillo, Julian R. Homburger, Genevieve L. Wojcik, Alissa L. Severson, Jonathan S. Friedlaender, Françoise Y. Friedlaender, Angela Allen, Stephen Allen, Mark Stoneking, Adrian V. S. Hill, George Aho, George Koki, William Pomat, Carlos D. Bustamante, Maude E. Phipps, Alexander J. Mentzer, Andrés Moreno‐Estrada, Alexander G. IoannidisarXiv 2024 · DOI · arXiv

Abstract

Encompassing regions that were amongst the first inhabited by humans following the out-of-Africa expansion, hosting populations with the highest levels of archaic hominid introgression, and including Pacific islands that are the most isolated inhabited locations on the planet, Oceania has a rich, but understudied, human genomic landscape. Here we describe the first region-wide analysis of genome-wide data from population groups spanning Oceania and its surroundings, from island and peninsular southeast Asia to Papua New Guinea, east across the Pacific through Melanesia, Micronesia, and Polynesia, and west across the Indian Ocean to related island populations in the Andamans and Madagascar. In total we generate and analyze genome-wide data from 981 individuals from 92 different populations, 58 separate islands, and 30 countries, representing the most expansive study of Pacific genetics to date. In each sample we disentangle the Papuan and more recent Austronesian ancestries, which have admixed in various proportions across this region, using ancestry-specific analyses, and characterize the distinct patterns of settlement, migration, and archaic introgression separately in these two ancestries. We also focus on the patterns of clinically relevant genetic variation across Oceania—a landscape rippled with strong founder effects and island-specific genetic drift in allele frequencies—providing an atlas for the development of precision genetic health strategies in this understudied region of the world.

Introduction

Oceania represents a region of geographical and evolutionary extremes. It was one of the primary destinations for early human migrations following the out-of-Africa expansion and remains home to populations with the highest recorded levels of archaic Denisovan introgression. Despite its unique position in human history, Oceania has long been a "black hole" in global genomic datasets. Previous research has often focused on isolated islands or specific sub-regions, leaving a significant gap in our understanding of the pan-Oceanian connections and the genetic legacy of its inhabitants.

This study addresses these gaps by presenting the most expansive genomic map of the region to date. By analyzing nearly 1,000 individuals across 92 populations, the research provides a comprehensive look at the settlement history, archaic heritage, and clinical genetic landscape of the Pacific.

Methodology and Data Integration

The study utilized the newly established Oceanian Genotype Variation Project (OGVP) dataset, which includes 981 individuals from 58 islands and 30 countries. Genotyping was performed using the MEGA-EX Illumina platform, covering approximately 1.8 million markers. To provide a global context, the researchers integrated this data with the Human Genome Diversity Project (HGDP) and ancient DNA samples from the Lapita culture in Vanuatu and Tonga.

To navigate the complex demographic history of the region, the team employed several specialized analytical techniques:

  • Ancestry Deconvolution: Using RFMix, the researchers separated ancient "Papuan" ancestry (dating back over 50,000 years) from the more recent "Austronesian" ancestry associated with the seafaring expansion that began roughly 3,500 years ago.
  • Identity by Descent (IBD): Shared DNA segments were analyzed to reconstruct recent migration paths and identify historical population bottlenecks.
  • Archaic Introgression Analysis: D-statistics and F4-ratio tests were used to quantify Denisovan and Neanderthal DNA by comparing modern samples against high-coverage archaic genomes.
  • Clinical Annotation: Variants were cross-referenced with ANNOVAR and CLINVAR to identify mutations with known impacts on drug response and disease susceptibility.

Rethinking Pacific Migration

One of the most significant findings of this study is the discovery of a westward "back-migration." While the traditional "express train" model suggests a unidirectional movement of Austronesian speakers from Asia into the remote Pacific, the genomic data reveals a more complex exchange. Evidence shows that populations from Western Polynesia (such as Samoa and Tonga) migrated back toward the Philippines, contributing to the genetic ancestry of groups like the Mamanwa and Manobo.

This discovery suggests that the Pacific was not merely a destination but a hub of bidirectional maritime activity, challenging long-held assumptions about the isolation of Polynesian voyagers after their initial expansion.

Archaic Heritage: The Denisovan Legacy

Oceania remains the global epicenter for Denisovan genetic legacy. The study found that Papuan Highlanders carry an average of 3.2% Denisovan DNA. Even in remote Oceania, where Austronesian ancestry is dominant, the Papuan-specific segments of the genome consistently maintain 2–5% Denisovan introgression.

Crucially, the data suggests that Denisovan DNA did not enter the Oceanian gene pool through a single event. Instead, the researchers identified evidence for multiple pulses of introgression—one occurring in the ancestors of Papuans and a separate, distinct pulse into the ancestors of Austronesian speakers. This indicates a complex series of interactions between modern humans and archaic hominids across Southeast Asia and the Pacific.

The "Island Effect" and Clinical Implications

The settlement of Oceania involved small founder groups colonizing isolated islands, a process that led to significant genetic drift. This "island effect" has caused certain genetic variants to reach high frequencies that are not seen elsewhere in the world, creating a unique landscape for precision medicine.

Key Clinical Findings:

  • Infectious Disease: A protective variant in the OAS1 gene, inherited from archaic hominids, is present in 58% of Papua New Guineans. This variant is associated with reduced severity in COVID-19 infections, highlighting how ancient introgression continues to influence modern health.
  • Pharmacogenomics: The researchers identified a variant in the SLCO1B1 gene that increases the risk of adverse side effects from statins (cholesterol-lowering medication). The frequency of this variant fluctuates wildly across the region, suggesting that standardized drug dosages may be inappropriate for many Pacific populations.
  • Metabolic Health: The SNP rs12513649, which is strongly associated with Body Mass Index (BMI), is highly prevalent across Polynesia. This genetic signature mirrors the high rates of obesity in the region and provides a biological context for metabolic health challenges.

Limitations and Future Directions

While this study provides a vital atlas of Oceanian genetics, it relies on SNP arrays, which are subject to ascertainment bias—they primarily detect variants already known in other global populations. To fully capture the rare, island-specific variants that define the Pacific, whole-genome sequencing (WGS) will be required.

Furthermore, the clinical associations noted in this study are largely based on data from European or East Asian cohorts. Future research must prioritize direct clinical trials and functional studies within Oceanian communities to ensure that the promise of precision medicine is equitably realized for the people of the Pacific.

Summary updated

Abstract

Encompassing regions that were amongst the first inhabited by humans following the out-of-Africa expansion, hosting populations with the highest levels of archaic hominid introgression, and including Pacific islands that are the most isolated inhabited locations on the planet, Oceania has a rich, but understudied, human genomic landscape. Here we describe the first region-wide analysis of genome-wide data from population groups spanning Oceania and its surroundings, from island and peninsular southeast Asia to Papua New Guinea, east across the Pacific through Melanesia, Micronesia, and Polynesia, and west across the Indian Ocean to related island populations in the Andamans and Madagascar. In total we generate and analyze genome-wide data from 981 individuals from 92 different populations, 58 separate islands, and 30 countries, representing the most expansive study of Pacific genetics to date. In each sample we disentangle the Papuan and more recent Austronesian ancestries, which have admixed in various proportions across this region, using ancestry-specific analyses, and characterize the distinct patterns of settlement, migration, and archaic introgression separately in these two ancestries. We also focus on the patterns of clinically relevant genetic variation across Oceania--a landscape rippled with strong founder effects and island-specific genetic drift in allele frequencies--providing an atlas for the development of precision genetic health strategies in this understudied region of the world.
BibTeX
@misc{quintocortes2024genomic,
  author = {Consuelo D. Quinto-Cortés and Carmina Barberena Jonas and Sofía Vieyra-Sánchez and Stephen Oppenheimer and Ram González-Buenfil and Kathryn Auckland and Kathryn Robson and Tom Parks and J. Víctor Moreno-Mayar and Javier Blanco-Portillo and Julian R. Homburger and Genevieve L. Wojcik and Alissa L. Severson and Jonathan S. Friedlaender and Françoise Y. Friedlaender and Angela Allen and Stephen Allen and Mark Stoneking and Adrian V. S. Hill and George Aho and George Koki and William Pomat and Carlos D. Bustamante and Maude E. Phipps and Alexander J. Mentzer and Andrés Moreno‐Estrada and Alexander G. Ioannidis},
  title = {{The Genomic Landscape of Oceania}},
  year = {2024},
  eprint = {2405.09216},
  archivePrefix = {arXiv},
  url = {https://arxiv.org/abs/2405.09216},
}
Figure